Abstract
This study aimed to develop an LC-MS/MS assay for the quantitation of S002-857 in plasma, urine and feces to evaluate the pharmacokinetic parameters and elimination pathway for further development of S002-857. A sensitive and selective LC-MS/MS method was developed and validated for estimating a novel antidiabetic flavone derivative, S002-857, synthesized by Central Drug Research Institute, CSIR, Lucknow, India. Plasma and urine samples were prepared by two-step liquid-liquid extraction with diethyl ether and feces by protein precipitation using acetonitrile. The analyte was chromatographed on a cyano column with methanol-ammonium acetate buffer (pH 4.6, 10 mM; 90:10, v/v). The calibration curves were linear over a range of 0.78–400 ng mL−1 for plasma and 1.56–400 ng mL−1 for urine and feces samples. The accuracy and precision were <15% for plasma, urine and feces samples. The recoveries from spiked plasma, urine and feces samples were >85%. S002-857 was stable in plasma for 8 h at ambient temperature, 30 days at −60 °C and after three freeze-thaw cycles. The assay was successfully applied to determine the pharmacokinetic parameters and excretion profile in male rats.
Similar content being viewed by others
References
Zhang SQ, Zhong XY, Chen GH, Lu WL, Zhang Q (2008) J Pharm Pharmacol 60:99–105
Siddharth NS (2001) J Diabetology 3:11
Larmer J (1985) Insulin and oral hypoglycemic drugs, glucogan. In: Gilman AG, Goodman LS, Rall TW, Murad F, (eds). The pharmacological basis of therapeutics, 7th edn. Macmillan, New York
Cook NC, Samman S (1996) J Nutr Biochem 7:66–76
Belinky PA, Aviram M, Mahmood S, Vaya J (1998) Free Radic Biol Med 24:1419–1429
Sharma B, Viswanath G, Salunke R, Roy P (2008) Food Chem 110(3): 697–705
Manach C, Donovan JL (2004) Free Radic Res 38:771–785
Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, Layloff T, Viswanathan CT, Cook CE, McDowall RD, Pittman KA, Spector S (1991) Eur J Drug Metab Pharmacokin 16:249–255
Jan WC, Lin LC, Don MJ, Chen CF, Tsai TH (2006) Biomed Chromatogr 20:1163–1171
Gautam N, Singh RP, Pratap R, Singh SK (2010) Biomed Chromatogr 24:692–698
Oswald S, Scheuch E, Cascorbi I, Siegmund W (2006) J Chromatogr B 830:143–150
Kostiainen R, Kotiaho T, Kuuranne T, Auriolo S (2003) J Mass Spectrom 38:357–372
Singh RP, Sabarinath S, Gautam N, Gupta RC, Singh SK (2009) J Chromatogr B 877:2074–2080
Suryawanshi S, Mehrotra N, Asthana RK, Gupta RC (2006) Rapid Commun Mass Spectrom 20:3761–3768
Xu W, Zhang Y, Yang M, Shen Z, Zhang X, Li H (2007) J Pharm Biomed Anal 45:667–672
Bi X, Meng Z, Dou G (2007) J Chromatogr B 850:199–205
Gautam N, Kushwaha HN, Pratap R, Singh SK (2010) J Pharm Pharmacol 62:604–609
Manach C, Donovan JL (2004) Free Radic Res 38:771–785
Acknowledgments
The authors are thankful to the director of CDRI for providing the facilities and infrastructure for the study. The authors also acknowledge to Council of Scientific and Industrial Research (CSIR) and University Grant Commission (UGC), New Delhi, India, for providing research fellowships. (CDRI Communication No. 8027)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gautam, N., Kushwaha, H.N., Kumar, H. et al. LC-MS/MS Assay for Quantification of a Novel Antidiabetic Flavone Derivative S002-857 in Rat Plasma, Urine and Feces: Application in Pharmacokinetic Studies. Chromatographia 73, 905–912 (2011). https://doi.org/10.1007/s10337-011-1978-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10337-011-1978-6